BamSEC and AlphaSense Join Forces
Learn More

TG Therapeutics Inc.

NASDAQ: TGTX    
Share price (12/20/24): $32.20    
Market cap (12/20/24): $5.012 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 54 pages (1) Fujifilm Diosynth Biotechnologies North Carolina, Inc.; (2) Fujifilm Diosynth Biotechnologies Denmark Aps and (3) TG Therapeutics, Inc
12/34/56
EX-10.2
from 10-Q 131 pages Financing Agreement Dated as of August 2, 2024 Among TG Therapeutics, Inc., as Borrower, Certain Subsidiaries of Borrower, as Guarantors, Various Lenders From Time to Time Party Hereto, and Blue Owl Capital Corporation, as Administrative Agent
12/34/56
EX-10.1
from 8-K 1 page Amendment to the TG Therapeutics, Inc. 2022 Incentive Plan
12/34/56
EX-10.38
from 10-K 79 pages Certain Information Marked as [***] Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. License Agreement by and Among TG Therapeutics, Inc., TG Cell Therapy, Inc. and Precision Biosciences, Inc. License Agreement
12/34/56
EX-10.1
from 10-Q 85 pages 1. Definitions
12/34/56
EX-10.8
from 10-Q 15 pages Warrant Agreement to Purchase Shares of the Common Stock of TG Therapeutics, Inc. Dated as of March 31, 2023
12/34/56
EX-10.7
from 10-Q 15 pages Warrant Agreement to Purchase Shares of the Common Stock of TG Therapeutics, Inc. Dated as of March 31, 2023
12/34/56
EX-10.6
from 10-Q 16 pages Warrant Agreement to Purchase Shares of the Common Stock of TG Therapeutics, Inc. Dated as of March 31, 2023
12/34/56
EX-10.5
from 10-Q 15 pages Amended and Restated Warrant Agreement to Purchase Shares of the Common Stock of TG Therapeutics, Inc. Dated as of March 31, 2023
12/34/56
EX-10.4
from 10-Q 15 pages Amended and Restated Warrant Agreement to Purchase Shares of the Common Stock of TG Therapeutics, Inc. Dated as of March 31, 2023
12/34/56
EX-10.3
from 10-Q 15 pages Amended and Restated Warrant Agreement to Purchase Shares of the Common Stock of TG Therapeutics, Inc. Dated as of March 31, 2023
12/34/56
EX-10.2
from 10-Q 16 pages Amended and Restated Warrant Agreement to Purchase Shares of the Common Stock of TG Therapeutics, Inc. Dated as of March 31, 2023
12/34/56
EX-10.1
from 8-K 18 pages TG Therapeutics, Inc. 2022 Incentive Plan Article 1 Purpose
12/34/56
EX-10.31
from 10-K 18 pages Warrant Agreement ​ to Purchase Shares of the Common Stock of ​ TG Therapeutics, Inc. ​ Dated as of December 30, 2021
12/34/56
EX-10.30
from 10-K 18 pages Warrant Agreement ​ to Purchase Shares of the Common Stock of ​ TG Therapeutics, Inc. ​ Dated as of December 30, 2021
12/34/56
EX-10.29
from 10-K 18 pages Warrant Agreement ​ to Purchase Shares of the Common Stock of ​ TG Therapeutics, Inc. ​ Dated as of December 30, 2021
12/34/56
EX-10.1
from 10-Q 17 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 8-K 2 pages ​ Amendment to the TG Therapeutics, Inc. Amended and Restated 2012 Incentive Plan
12/34/56
EX-10.2
from 10-Q 29 pages Master Services Agreement Between Samsung Biologics Co., Ltd. and TG Therapeutics, Inc. 1
12/34/56
EX-10.1
from 10-Q 24 pages Amended and Restated Collaboration Agreement
12/34/56